The changing pattern of bloodstream infection in pediatric oncology patients in the United Arab Emirates

Pediatric Hematology and Oncology

Volumn 20, Issue 4, 2003, Pages 281-289

  Trad, O ^a   Jumaa, Pauline A ^a   Afify, Z ^a  

^a TAWAM HOSPITAL   (United Arab Emirates)

Author keywords

Bacteremia; Blood cultures; Empirical therapy; Neutropenia; Pediatric oncology

Indexed keywords

AMIKACIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; FLUCLOXACILLIN; GENTAMICIN; IMIPENEM; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BLOOD CULTURE; CANCER PATIENT; CHILD; CHILDHOOD CANCER; ENTEROBACTER; ENTEROCOCCUS; FEBRILE NEUTROPENIA; FEMALE; FUNGEMIA; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; INFANT; INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PSEUDOMONAS AERUGINOSA; UNITED ARAB EMIRATES;

EID: 0038101629     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010390203044     Document Type: Article

References (24)

1. Viscoli C, Castagnola E, Giacchino M, et al. Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology Supportive Therapy Group-Infectious Diseases Section. Eur J Cancer. 1999;35:770-774.
2. Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteraemia and fungaemia in adult. Rev Infect Dis. 1983;5:54-70.
3. Gray JW, Pedler SJ, Craft AW, et al. Changing causes of septicaemia in paediatric oncology patients: effect of imipenem use. Eur J Pediatr. 1994;153:84-89.
4. Aquino VM, Pappo A, Buchanan GR, et al. The changing epidemiology of bacteremia in neutropenic children with cancer. Pediatr Infect Dis. 1995;14:140-143.
5. Aledo A, Heller G, Ren L, et al. Septicaemia and septic shock in pediatric patients: 140 consecutive cases on a pediatric hematology oncology service. J Pediatr Hematol Oncol. 1998;20:215-220.
6. Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6 year-validated, population-based model. Clin Infect Dis. 1997;24:1068-1078.
7. O'Brien TF. The global nature of antimicrobial resistance and the need to monitor and manage it locally. Clin Infect Dis. 1997;24(suppl 2):S2-S8.
8. Rice LB. Bacterial monopolists: the bundling and dissemination of antimicrobial resistance genes in gram positive bacteria. Clin Infect Dis. 2000;31:762-769.
9. Hart CA, Kaniuki S. Antimicrobial resistance in developing countries. BMJ. 1998;317:647-650.
10. Mahmood S, Revesz T, Mpofu C. Febrile episodes in children with cancer in the United Arab Emirates. Pediatr Hematol Oncol. 1996;13:135-142.
11. International Antimicrobial Therapy Cooperative Group of the EORTC. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram negative bacteremia in cancer patients with granulocytopenia. N Engl J Med. 1987;317:1692-1698.
12. Hughes WT, Rivera G, Schell M, et al. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med. 1987;316:1627.
13. Poulsen A, Demeny AK, Bang Plum C, et al. Pneumocystis carinii pneumonia during maintenance treatment of childhood acute lymphoblastic leukemia. Med Pediatr Oncol. 2001;37:20-23.
14. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for Antimicrobial Susceptibility Testing. Villanova, PA: NCCLS; 2000.
15. Microsoft Office 2000. Redmond, WA: Microsoft Corporation.
16. EpiInfo Version 6.02: A Word Processing Database and Statistics Programme for Epidemiology on Microcomputers. Atlanta, GA: Centers for Disease Control and Prevention; 1994.
17. Gunther G, Bjorkholm M, Bjorklind A, et al. Septicaemia in patients with haematological disorders and neutropenia. Scand J Infect Dis. 1991;23:589-598.
18. Negri MC, Morosini MI, Blazquez J, Baquero F. Antibiotic resistance in hospital infections: the role of the newer cephalosporins. Clin Microbiol Infect. 2000;6(Suppl 3):95-97.
19. Bradley SJ, Wilson ALT, Allen MC, et al. The control of hyperendemic glycopeptide resistant Enterococcus spp in a haematology unit by changing antibiotic usage. J Antimicrob Chemother 1999;43:261-266.
20. Micozzi A, Venditti M, Monaco M, et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematological malignancies. Clin Infect Dis. 2000;31:705-711.
21. Correa L, Pittet D. Problems and solutions in hospital-acquired bacteraemia. J Hosp Infect. 2000;46:89-95.
22. Jumaa PA, Chattopadhyay B. Pseudobacteraemia. J Hosp Infect. 1994;27:167-177.
23. Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev. 1998;11:57-80.
24. Viscoli C, Girmenia C, Marinus A, et al. Candidaemia in cancer patients: a prospective multicentre surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organisation for Research and Treatment of Cancer (EORTC). Clin Infect Dis. 1999;28:1071-1079.